Name | adenosine 5'-methylenediphosphate |
---|---|
Synonyms |
Dimethylepoxypropionamide
3,3-Dimethyl-glycidsaeure-amid Adenosine 5'-methylenediphosphate 9-{5-O-[Hydroxy(phosphonomethyl)phosphoryl]pentofuranosyl}-9H-pur in-6-amine 2-Aminocarbonyl-3-methyloxiran 3,3-dimethyl-oxiranecarboxylic acid amide 2,3-Epoxy-3-methylbutyramide Oxiranecarboxamide,3,3-dimethyl BUTYRAMIDE,2,3-EPOXY-3-METHYL Dimethylepoxypropionamide [French] |
Description | MethADP is a specific CD73 inhibitor. |
---|---|
Related Catalog | |
Target |
CD73[1]. |
In Vitro | MethADP (AMP-CP: 20 μM) causes a marked inhibition of adenosine formation (0.96±0.96 μM) compared to untreated controls (9.6±1.5 μM) in A498 and RT4 cells, and MethADP (100 μM) completely inhibits the adenosine formation[1]. |
References |
Density | 2.35g/cm3 |
---|---|
Boiling Point | 895.6ºC at 760mmHg |
Molecular Formula | C11H17N5O9P2 |
Molecular Weight | 425.22800 |
Flash Point | 495.4ºC |
Exact Mass | 425.05000 |
PSA | 242.99000 |
Index of Refraction | 1.885 |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
Hazard Codes | Xi |
Safety Phrases | 22-24/25 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
Precursor 2 | |
---|---|
DownStream 0 |